PharmaCyte Biotech (PMCB) Cash from Investing Activities (2011 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Cash from Investing Activities of $5.0 million for Q1 2026, up 266.67% quarter-over-quarter from -$3.0 million in Q4 2025.
PharmaCyte Biotech (PMCB) Cash from Investing Activities (2011 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Cash from Investing Activities for 7 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to $5.0 million; the TTM figure through Apr 2026 stood at $2.0 million (up 128.57% YoY), while the FY2026 annual figure was $2.0 million, up 128.57% from the prior year.
- Cash from Investing Activities improved to $5.0 million in Q1 2026 per PMCB's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5.0 million in Q1 2026 and bottomed at -$7.0 million in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$2.5 million across 3 years, with a median of -$4.0 million in 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 5.00 Mn |
| Jan 31, 2026 | 5.00 Mn |
| Oct 31, 2025 | -3.00 Mn |
| Oct 31, 2025 | -3.00 Mn |
| Jul 31, 2024 | -7.00 Mn |
| Jul 31, 2024 | -7.00 Mn |
| Jan 31, 2024 | -5.00 Mn |
| Jan 31, 2024 | -5.00 Mn |
| Apr 30, 2014 | -1.01 Mn |
| Apr 30, 2014 | -1.01 Mn |
| Oct 31, 2013 | -982,365.00 |
| Oct 31, 2013 | -982,365.00 |
| Jul 31, 2013 | -1.57 Mn |
| Jul 31, 2013 | -1.57 Mn |
| Apr 30, 2013 | -165,000.00 |
| Apr 30, 2013 | -165,000.00 |
| Jan 31, 2013 | -160,000.00 |
| Jan 31, 2013 | -160,000.00 |
| Oct 31, 2012 | -126,000.00 |
| Oct 31, 2012 | -126,000.00 |